Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach
- 1 June 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (6) , 1189-1196
- https://doi.org/10.1038/sj.leu.2402516
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 33 references indexed in Scilit:
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionPublished by Elsevier ,2003
- Quantitative Imaging of Lateral ErbB1 Receptor Signal Propagation in the Plasma MembraneScience, 2000
- Box 3-independent Signaling Mechanisms Are Involved in Leukemia Inhibitory Factor Receptor α- and gp130-mediated Stimulation of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1997
- Interleukin‐6: Structure‐function relationshipsProtein Science, 1997
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- Involvement of Stat3 in interleukin‐6‐induced IgM production in a human B‐cell lineImmunology, 1997
- Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-ApoptosisImmunity, 1996
- Interleukin‐6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP‐1European Journal of Immunology, 1996
- Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells.The Journal of Experimental Medicine, 1995
- Tyrosine Phosphorylation of Jak-Tyk Kinases in Malignant Plasma Cell Lines Growth Stimulated by Interleukins 6 and 11Biochemical and Biophysical Research Communications, 1994